1. Home
  2. RMD vs CTVA Comparison

RMD vs CTVA Comparison

Compare RMD & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • CTVA
  • Stock Information
  • Founded
  • RMD 1989
  • CTVA 2018
  • Country
  • RMD United States
  • CTVA United States
  • Employees
  • RMD N/A
  • CTVA N/A
  • Industry
  • RMD Medical/Dental Instruments
  • CTVA Farming/Seeds/Milling
  • Sector
  • RMD Health Care
  • CTVA Consumer Staples
  • Exchange
  • RMD Nasdaq
  • CTVA Nasdaq
  • Market Cap
  • RMD 35.7B
  • CTVA 39.1B
  • IPO Year
  • RMD 1995
  • CTVA N/A
  • Fundamental
  • Price
  • RMD $228.49
  • CTVA $56.35
  • Analyst Decision
  • RMD Buy
  • CTVA Buy
  • Analyst Count
  • RMD 12
  • CTVA 18
  • Target Price
  • RMD $230.11
  • CTVA $65.31
  • AVG Volume (30 Days)
  • RMD 728.5K
  • CTVA 3.1M
  • Earning Date
  • RMD 01-22-2025
  • CTVA 02-05-2025
  • Dividend Yield
  • RMD 0.93%
  • CTVA 1.20%
  • EPS Growth
  • RMD 22.60
  • CTVA N/A
  • EPS
  • RMD 7.54
  • CTVA 0.98
  • Revenue
  • RMD $4,807,485,000.00
  • CTVA $16,637,000,000.00
  • Revenue This Year
  • RMD $10.22
  • CTVA $0.62
  • Revenue Next Year
  • RMD $7.16
  • CTVA $2.34
  • P/E Ratio
  • RMD $30.30
  • CTVA $57.36
  • Revenue Growth
  • RMD 9.88
  • CTVA N/A
  • 52 Week Low
  • RMD $164.12
  • CTVA $44.01
  • 52 Week High
  • RMD $260.49
  • CTVA $64.20
  • Technical
  • Relative Strength Index (RSI)
  • RMD 37.96
  • CTVA 37.99
  • Support Level
  • RMD $228.11
  • CTVA $56.22
  • Resistance Level
  • RMD $234.75
  • CTVA $57.92
  • Average True Range (ATR)
  • RMD 5.64
  • CTVA 1.19
  • MACD
  • RMD -0.96
  • CTVA -0.18
  • Stochastic Oscillator
  • RMD 16.99
  • CTVA 5.01

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About CTVA Corteva Inc.

Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.

Share on Social Networks: